When was LA TRANSFUSION DU SANG founded?

LA TRANSFUSION DU SANG was founded on 17 Sep 1935, making it 91 years old.

Is LA TRANSFUSION DU SANG still active?

Yes, LA TRANSFUSION DU SANG is currently active.

Where is LA TRANSFUSION DU SANG registered?

LA TRANSFUSION DU SANG's registered address is Boulevard Joseph II 11B, 6000 Charleroi, Belgium.

How many employees does LA TRANSFUSION DU SANG have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2025), LA TRANSFUSION DU SANG reported 32.5 full-time equivalent employees.

What is LA TRANSFUSION DU SANG's annual turnover?

LA TRANSFUSION DU SANG's most recently filed annual turnover (fiscal year ending 31 Dec 2025) was €4,813,091.

Did LA TRANSFUSION DU SANG make a profit or a loss?

LA TRANSFUSION DU SANG's most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a loss of €114,590.

When did LA TRANSFUSION DU SANG last file annual accounts?

LA TRANSFUSION DU SANG's most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.

Is LA TRANSFUSION DU SANG B Corp certified?

We have no B Corp certification on file for LA TRANSFUSION DU SANG.

Does LA TRANSFUSION DU SANG hold Fairtrade certification?

No, LA TRANSFUSION DU SANG does not currently hold Fairtrade certification.

LA TRANSFUSION DU SANG

Q: What does LA TRANSFUSION DU SANG do?

LA TRANSFUSION DU SANG's registered main activity is Activities of blood collection centres, blood banks, sperm banks, transplant organ banks and similar establishments.

BE 0401.574.357

Copied!

VZW/ASBL

Status

Active

Founded

17 Sep 1935 · 91 yrs

Size

Small · 32.5 FTE

Legal name

ETABLISSEMENT LA TRANSFUSION DU SANG

Main activity

Activities of blood collection centres, blood banks, sperm banks, transplant organ banks and similar establishments

Website

dondesang.be

Activities

1 activity

Activities of blood collection centres, blood banks, sperm banks, transplant organ banks and similar establishments

Financials

Turnover2025

€4.8M+5.6%

Profit / Loss2025

−€115K+74.5%

Equity2025

€2.5M-4.4%

2025	2024	2023	2022
€4,813,091+5.6%	€4,558,264-5.5%	€4,823,492-6.4%	€5,156,301
-€114,590+74.5%	-€448,489-46.9%	-€305,342-446.5%	-€55,867
€2,491,500-4.4%	€2,606,090-14.7%	€3,054,579-9.1%	€3,359,921
€791,857-24.2%	€1,044,780+28.9%	€810,857-8.1%	€882,302
€506,646-22.1%	€650,795+13.2%	€574,726-69%	€1,853,084
32.5-5%	34.2-2.8%	35.2+8.3%	32.5
€148,095+11.1%	€133,283-2.7%	€137,031-13.6%	€158,655

Frequently asked questions

01What is LA TRANSFUSION DU SANG's official registered name?

ETABLISSEMENT LA TRANSFUSION DU SANG.

02What is LA TRANSFUSION DU SANG's enterprise number (VAT number)?

BE 0401.574.357.

03What is LA TRANSFUSION DU SANG's legal form?

Vereniging zonder winstoogmerk (VZW) / Association sans but lucratif (ASBL).

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

	2025	2024	2023	2022
Income statement
	€4,813,091+5.6%	€4,558,264-5.5%	€4,823,492-6.4%	€5,156,301
	€2,577,948+11.3%	€2,316,778+1.3%	€2,287,988-0.6%	€2,301,874
	€2,590,227-4.5%	€2,711,052+8.7%	€2,494,962+11.6%	€2,235,925
	€111,264-59.1%	€272,094+933.1%	€26,339-79.6%	€128,964
	-€135,549+72.3%	-€488,781-44.1%	-€339,259-443.9%	-€62,370
	—	—	-€252,629	—
	-€114,590+74.5%	-€448,489-46.9%	-€305,342-446.5%	-€55,867
	€59,817+42.8%	€41,897-30.4%	€60,238-16.9%	€72,508
Profitability
	53.6%+5.4%	50.8%+7.2%	47.4%+6.3%	44.6%
	—	—	-5.2%	—
	-2.4%+75.8%	-9.8%-55.4%	-6.3%-484.3%	-1.1%
	-4.6%+73.3%	-17.2%-72.2%	-10.0%-501.2%	-1.7%
	-3.5%+71.6%	-12.3%-55.5%	-7.9%-499.8%	-1.3%
Solvency
	€3,283,357-10.1%	€3,650,870-5.5%	€3,865,436-8.9%	€4,242,223
	€621,293-1.1%	€628,027+39.8%	€449,198-11.8%	€509,289
	€1,565-6%	€1,6650%	€1,6650%	€1,665
	€2,491,500-4.4%	€2,606,090-14.7%	€3,054,579-9.1%	€3,359,921
	75.9%+6.3%	71.4%-9.7%	79.0%-0.2%	79.2%
	€791,857-24.2%	€1,044,780+28.9%	€810,857-8.1%	€882,302
	0.32-20.7%	0.40+51%	0.27+1.1%	0.26
Liquidity
	€506,646-22.1%	€650,795+13.2%	€574,726-69%	€1,853,084
	€518,702+46.2%	€354,874+35.9%	€261,213-26%	€353,070
	€945,331+31.4%	€719,542-3.3%	€744,520-24.4%	€984,865
	€399,046-35.8%	€621,919+53.5%	€405,123-20.1%	€506,929
	€790,604-24.1%	€1,041,856+28.5%	€810,857-8.1%	€882,302
	2.72+19.9%	2.27-35.2%	3.50+64.5%	2.13
	€1,868,642-5.4%	€1,976,398-24.1%	€2,603,716-8.6%	€2,848,967
Efficiency
	72 days+24.4%	58 days+2.3%	56 days-19.2%	70 days
Profit appropriation
	€2,107,4400%	€2,107,4400%	€2,107,4400%	€2,107,440
	-€1,020,940-12.6%	-€906,350-97.9%	-€457,861-200.2%	-€152,519

Sources

NBB — Nationale Bank van België

	2025	2024	2023	2022
Income statement
	€4,813,091+5.6%	€4,558,264-5.5%	€4,823,492-6.4%	€5,156,301
	€2,577,948+11.3%	€2,316,778+1.3%	€2,287,988-0.6%	€2,301,874
	€2,590,227-4.5%	€2,711,052+8.7%	€2,494,962+11.6%	€2,235,925
	€111,264-59.1%	€272,094+933.1%	€26,339-79.6%	€128,964
	-€135,549+72.3%	-€488,781-44.1%	-€339,259-443.9%	-€62,370
	—	—	-€252,629	—
	-€114,590+74.5%	-€448,489-46.9%	-€305,342-446.5%	-€55,867
	€59,817+42.8%	€41,897-30.4%	€60,238-16.9%	€72,508
Profitability
	53.6%+5.4%	50.8%+7.2%	47.4%+6.3%	44.6%
	—	—	-5.2%	—
	-2.4%+75.8%	-9.8%-55.4%	-6.3%-484.3%	-1.1%
	-4.6%+73.3%	-17.2%-72.2%	-10.0%-501.2%	-1.7%
	-3.5%+71.6%	-12.3%-55.5%	-7.9%-499.8%	-1.3%
Solvency
	€3,283,357-10.1%	€3,650,870-5.5%	€3,865,436-8.9%	€4,242,223
	€621,293-1.1%	€628,027+39.8%	€449,198-11.8%	€509,289
	€1,565-6%	€1,6650%	€1,6650%	€1,665
	€2,491,500-4.4%	€2,606,090-14.7%	€3,054,579-9.1%	€3,359,921
	75.9%+6.3%	71.4%-9.7%	79.0%-0.2%	79.2%
	€791,857-24.2%	€1,044,780+28.9%	€810,857-8.1%	€882,302
	0.32-20.7%	0.40+51%	0.27+1.1%	0.26
Liquidity
	€506,646-22.1%	€650,795+13.2%	€574,726-69%	€1,853,084
	€518,702+46.2%	€354,874+35.9%	€261,213-26%	€353,070
	€945,331+31.4%	€719,542-3.3%	€744,520-24.4%	€984,865
	€399,046-35.8%	€621,919+53.5%	€405,123-20.1%	€506,929
	€790,604-24.1%	€1,041,856+28.5%	€810,857-8.1%	€882,302
	2.72+19.9%	2.27-35.2%	3.50+64.5%	2.13
	€1,868,642-5.4%	€1,976,398-24.1%	€2,603,716-8.6%	€2,848,967
Efficiency
	72 days+24.4%	58 days+2.3%	56 days-19.2%	70 days
Profit appropriation
	€2,107,4400%	€2,107,4400%	€2,107,4400%	€2,107,440
	-€1,020,940-12.6%	-€906,350-97.9%	-€457,861-200.2%	-€152,519

2025

2024

2023

2022

Income statement

€4,813,091+5.6%

€4,558,264-5.5%

€4,823,492-6.4%

€5,156,301

€2,577,948+11.3%

€2,316,778+1.3%

€2,287,988-0.6%

€2,301,874

€2,590,227-4.5%

€2,711,052+8.7%

€2,494,962+11.6%

€2,235,925

€111,264-59.1%

€272,094+933.1%

€26,339-79.6%

€128,964

-€135,549+72.3%

-€488,781-44.1%

-€339,259-443.9%

-€62,370

—

-€252,629

—

-€114,590+74.5%

-€448,489-46.9%

-€305,342-446.5%

-€55,867

€59,817+42.8%

€41,897-30.4%

€60,238-16.9%

€72,508

Profitability

53.6%+5.4%

50.8%+7.2%

47.4%+6.3%

44.6%

—

-5.2%

—

-2.4%+75.8%

-9.8%-55.4%

-6.3%-484.3%

-1.1%

-4.6%+73.3%

-17.2%-72.2%

-10.0%-501.2%

-1.7%

-3.5%+71.6%

-12.3%-55.5%

-7.9%-499.8%

-1.3%

Solvency

€3,283,357-10.1%

€3,650,870-5.5%

€3,865,436-8.9%

€4,242,223

€621,293-1.1%

€628,027+39.8%

€449,198-11.8%

€509,289

€1,565-6%

€1,6650%

€1,665

€2,491,500-4.4%

€2,606,090-14.7%

€3,054,579-9.1%

€3,359,921

75.9%+6.3%

71.4%-9.7%

79.0%-0.2%

79.2%

€791,857-24.2%

€1,044,780+28.9%

€810,857-8.1%

€882,302

0.32-20.7%

0.40+51%

0.27+1.1%

0.26

Liquidity

€506,646-22.1%

€650,795+13.2%

€574,726-69%

€1,853,084

€518,702+46.2%

€354,874+35.9%

€261,213-26%

€353,070

€945,331+31.4%

€719,542-3.3%

€744,520-24.4%

€984,865

€399,046-35.8%

€621,919+53.5%

€405,123-20.1%

€506,929

€790,604-24.1%

€1,041,856+28.5%

€810,857-8.1%

€882,302

2.72+19.9%

2.27-35.2%

3.50+64.5%

2.13

€1,868,642-5.4%

€1,976,398-24.1%

€2,603,716-8.6%

€2,848,967

Efficiency

72 days+24.4%

58 days+2.3%

56 days-19.2%

70 days

Profit appropriation

€2,107,4400%

€2,107,440

-€1,020,940-12.6%

-€906,350-97.9%

-€457,861-200.2%

-€152,519

LA TRANSFUSION DU SANG

Activities

Financials

Frequently asked questions

All locations

All locations